Related Experiment Video
Updated: Aug 15, 2026

11:17
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Provider class actions against MCOs: the march toward trial
1Crowell & Moring LLP, Washington, DC, USA. aposner@crowell.com
Summary
The In re Managed Care lawsuit, a major class-action against the managed care industry, continues after five years. Remaining defendants will let a jury decide on managed care practices and potential racketeering by managed care organizations (MCOs).
Area of Science:
- Healthcare Law
- Litigation Analysis
- Managed Care Industry
Background:
- The In re Managed Care case represents a significant class-action lawsuit targeting the managed care industry.
- This litigation has been ongoing for over five years, indicating its complexity and importance.
Purpose of the Study:
- To analyze the current status and key developments in the In re Managed Care lawsuit.
- To understand the implications of ongoing litigation for managed care organizations (MCOs) and industry practices.
Main Methods:
- Review of legal proceedings and case filings.
- Analysis of settlement trends among major industry players.
- Identification of key defendants proceeding to trial.
Main Results:
- Numerous large managed care companies have opted to settle the case.
- A subset of defendants remains committed to contesting the allegations through a jury trial.
- The core issues involve the validity of managed care practices and allegations of racketeering.
Conclusions:
- The In re Managed Care lawsuit remains a pivotal legal battle for the managed care sector.
- The decision to proceed to trial by remaining defendants suggests a willingness to challenge established practices and racketeering claims.
- The case's outcome could significantly impact future managed care operations and regulations.
Related Concept Videos
Torts III
Types of Quasi-intentional Torts in Healthcare
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
Torts II
Intentional torts in healthcare refer to deliberate actions that cause harm or infringe on the rights of others. Understanding these torts is crucial for healthcare professionals to avoid legal liabilities and maintain ethical standards in patient care.
Trial and Error and Algorithm
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light bulb,...
Power System Three-Phase Short Circuits
Determining the subtransient fault current in a power system involves representing transformers by their leakage reactances, transmission lines by their equivalent series reactances, and synchronous machines as constant voltage sources behind their subtransient reactances. In this analysis, certain elements are excluded, such as winding resistances, series resistances, shunt admittances, delta-Y phase shifts, armature resistance, saturation, saliency, non-rotating impedance loads, and small...
Formal Charges
In some cases, there are seemingly more than one valid Lewis structures for molecules and polyatomic ions. The concept of formal charges can be used to help predict the most appropriate Lewis structure when more than one reasonable structure exists.
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

